Panion & Bf Biotech Inc. (TPE:1760)

Market Cap	5.47B
Revenue (ttm)	2.04B
Net Income (ttm)	174.37M
Shares Out	85.74M
EPS (ttm)	2.03
PE Ratio	31.43
Forward PE	n/a
Dividend	1.80 (2.83%)
Ex-Dividend Date	Jun 12, 2025

Volume	113,304
Average Volume	122,616
Open	63.80
Previous Close	63.80
Day's Range	63.10 - 64.00
52-Week Range	56.00 - 89.90
Beta	-0.08
RSI	46.43
Earnings Date	Mar 9, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1976
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1760

Financial Performance

In 2024, Panion & Bf Biotech's revenue was 2.03 billion, an increase of 7.85% compared to the previous year's 1.88 billion. Earnings were 124.52 million, an increase of 61.26%.